SCHEMBL24313634

SCHEMBL24313634

O=C(N[S+]([O-])c1ccccc1)c1cc2c(F)cc(C3CC3)cc2o1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.34
ALDH1A1 P00352 4/20 0.34
NPC1 O15118 3/20 0.34
KDM4E B2RXH2 3/20 0.34
HTT P42858 2/20 0.34
NR1I2 O75469 1/20 0.34
HPGD P15428 1/20 0.34
AHR P35869 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
MCHR1 Q99705 4/20 0.34
KCNH2 Q12809 3/20 0.34
USP5 P45974 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
ALB P02768 1/20 0.33
IL2 P60568 1/20 0.33
LMNA P02545 2/20 0.33
MAPK1 P28482 1/20 0.33
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32
MAOB P27338 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24313801 0.87 RAB9A (0.36) RAB9AALDH1A1NPC1KDM4EHTT
SCHEMBL24313727 0.86 MAPK1 (0.33) RAB9AALDH1A1NPC1KDM4EHTT
SCHEMBL24313756 0.85 LMNA (0.33) RAB9AALDH1A1NPC1KDM4EHTT
SCHEMBL24313907 0.84 PDE2A (0.34) RAB9AALDH1A1NPC1KDM4EHTT
SCHEMBL24313750 0.83 KAT2B (0.33) RAB9AALDH1A1NPC1KDM4EHTT
SCHEMBL24314319 0.82 CNR2 (0.33) RAB9ANPC1MCHR1KCNH2USP5
SCHEMBL24313754 0.81 MEN1 (0.36) ALDH1A1KDM4EHTTHPGDSMN1; SMN2
SCHEMBL24313775 0.79 MCHR1 (0.38) MCHR1KCNH2MAOBALOX5MAOA
SCHEMBL24313633 0.77 HPGD (0.44) KDM4EHPGDLMNAKMT2A
SCHEMBL24314181 0.76 MCL1 (0.41) ALDH1A1KDM4EHTTHPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022081842-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO disclosed